Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...

Weight-loss injections such as GLP-1 receptor agonists (including semaglutide and tirzepatide) have transformed obesity ...

A new daily pill could offer a major breakthrough for people living with type 2 diabetes and struggling with weight management ...

B.C. Health Minister Josie Osborne says the funding is a game changer and will benefit more than half a million residents who are living with diabetes and about 160,000 people with menopausal symptoms ...

A new pill could help patients lose more weight and gain better control of their blood sugar levels than current weight loss medications, a promising new study has found.

Ahmedabad: Zydus Lifesciences Limited said it plans to launch semaglutide injection in India under the brand names Semaglyn, Mashema and Alterme after.

Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...

A single reusable pen could make costly GLP-1 therapy more affordable and accessible for millions of Indians battling diabetes and obesity.

aInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA bSchool of Medicine, University of Washington, Seattle, WA, USA cGeneral Medicine Service, Department of ...

The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to ...

Here’s something big: scientists in China have actually reversed type 2 diabetes using stem-cell therapy. It’s a major step ...